ICU Medical Inc
ICUI129.373USD
+1.972+1.55%
Market hours （ET）Quotes delayed by 15 min
3.18BMarket Cap
LossP/E TTM
More Details of ICU Medical Inc Company
ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needle free IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy product include Portex BLUselect PVC tracheostomy tubes.
Company Info
Ticker SymbolICUI
Company nameICU Medical Inc
IPO dateMar 31, 1992
CEOMr. Vivek Jain
Number of employees15000
Security typeOrdinary Share
Fiscal year-endMar 31
Address951 Calle Amanecer
CitySAN CLEMENTE
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code92673-6212
Phone19493662183
Websitehttps://www.icumed.com/
Ticker SymbolICUI
IPO dateMar 31, 1992
CEOMr. Vivek Jain
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Vivek Jain
Mr. Vivek Jain
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
196.92K
+1.88%
Mr. Brian Michael Bonnell
Mr. Brian Michael Bonnell
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
30.35K
+21.62%
Mr. Daniel (Dan) Woolson
Mr. Daniel (Dan) Woolson
President
President
14.19K
+30.63%
Mr. David C. Greenberg, J.D.
Mr. David C. Greenberg, J.D.
Lead Independent Director
Lead Independent Director
7.26K
+31.12%
Mr. Christian B. Voigtlander
Mr. Christian B. Voigtlander
Chief Operating Officer
Chief Operating Officer
6.09K
+154.83%
Mr. David F. Hoffmeister
Mr. David F. Hoffmeister
Independent Director
Independent Director
4.75K
+56.92%
Ms. Laurie Hernandez
Ms. Laurie Hernandez
Independent Director
Independent Director
3.61K
+91.41%
Ms. Kolleen T. Kennedy
Ms. Kolleen T. Kennedy
Independent Director
Independent Director
3.29K
+110.31%
Ms. Elisha W. Finney
Ms. Elisha W. Finney
Independent Director
Independent Director
3.25K
+52.75%
Mr. Donald M. Abbey
Mr. Donald M. Abbey
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Vivek Jain
Mr. Vivek Jain
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
196.92K
+1.88%
Mr. Brian Michael Bonnell
Mr. Brian Michael Bonnell
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
30.35K
+21.62%
Mr. Daniel (Dan) Woolson
Mr. Daniel (Dan) Woolson
President
President
14.19K
+30.63%
Mr. David C. Greenberg, J.D.
Mr. David C. Greenberg, J.D.
Lead Independent Director
Lead Independent Director
7.26K
+31.12%
Mr. Christian B. Voigtlander
Mr. Christian B. Voigtlander
Chief Operating Officer
Chief Operating Officer
6.09K
+154.83%
Mr. David F. Hoffmeister
Mr. David F. Hoffmeister
Independent Director
Independent Director
4.75K
+56.92%
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Consumables
266.23M
44.03%
Vital Care
172.18M
28.47%
Infusion Systems
166.30M
27.50%
By RegionUSD
Name
Revenue
Proportion
United States
388.25M
64.20%
EMEA
95.69M
15.82%
Others
61.36M
10.15%
APAC
59.41M
9.82%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Consumables
266.23M
44.03%
Vital Care
172.18M
28.47%
Infusion Systems
166.30M
27.50%
Shareholding Stats
Updated: Fri, May 16
Updated: Fri, May 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.27%
The Vanguard Group, Inc.
10.71%
Janus Henderson Investors
10.03%
Fuller & Thaler Asset Management Inc.
5.62%
State Street Global Advisors (US)
3.65%
Other
56.71%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.27%
The Vanguard Group, Inc.
10.71%
Janus Henderson Investors
10.03%
Fuller & Thaler Asset Management Inc.
5.62%
State Street Global Advisors (US)
3.65%
Other
56.71%
Shareholder Types
Shareholders
Proportion
Investment Advisor
48.22%
Investment Advisor/Hedge Fund
42.32%
Hedge Fund
6.10%
Research Firm
2.56%
Corporation
1.91%
Pension Fund
1.35%
Individual Investor
1.14%
Sovereign Wealth Fund
1.10%
Bank and Trust
0.55%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
607
25.92M
105.32%
-2.09M
2025Q1
626
27.13M
110.25%
-2.28M
2024Q4
608
26.46M
107.92%
-3.56M
2024Q3
587
26.75M
109.35%
-2.77M
2024Q2
567
27.24M
111.60%
-1.50M
2024Q1
579
26.01M
106.82%
-1.69M
2023Q4
588
25.74M
106.69%
-1.14M
2023Q3
580
26.53M
109.94%
-1.49M
2023Q2
580
26.62M
110.47%
-2.27M
2023Q1
598
27.04M
112.38%
-1.56M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
3.27M
13.27%
-99.77K
-2.96%
Mar 31, 2025
The Vanguard Group, Inc.
2.64M
10.71%
-39.79K
-1.49%
Mar 31, 2025
Janus Henderson Investors
2.47M
10.03%
+18.73K
+0.76%
Apr 30, 2025
Fuller & Thaler Asset Management Inc.
1.38M
5.62%
-11.46K
-0.82%
Mar 31, 2025
State Street Global Advisors (US)
899.31K
3.65%
-36.99K
-3.95%
Mar 31, 2025
Fidelity Management & Research Company LLC
727.77K
2.96%
+337.67K
+86.56%
Mar 31, 2025
Columbia Threadneedle Investments (US)
671.44K
2.73%
+108.47K
+19.27%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
631.48K
2.57%
+91.50K
+16.94%
Mar 31, 2025
Schroder Investment Management North America Inc.
621.95K
2.53%
+122.18K
+24.45%
Mar 31, 2025
JP Morgan Asset Management
621.77K
2.53%
+36.93K
+6.32%
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
Invesco S&P SmallCap Health Care ETF
2.33%
SPDR S&P Health Care Equipment ETF
1.79%
Invesco S&P SmallCap Momentum ETF
0.78%
Invesco S&P SmallCap 600 Pure Growth ETF
0.75%
JPMorgan Active Small Cap Value ETF
0.74%
JPMorgan Fundamental Data Science Small Core ETF
0.71%
Zacks Small/Mid Cap ETF
0.65%
SPDR S&P 600 Small Cap Growth ETF
0.47%
Vanguard S&P Small-Cap 600 Growth Index Fund
0.47%
iShares S&P Small-Cap 600 Growth ETF
0.45%
View more
Invesco S&P SmallCap Health Care ETF
Proportion2.33%
SPDR S&P Health Care Equipment ETF
Proportion1.79%
Invesco S&P SmallCap Momentum ETF
Proportion0.78%
Invesco S&P SmallCap 600 Pure Growth ETF
Proportion0.75%
JPMorgan Active Small Cap Value ETF
Proportion0.74%
JPMorgan Fundamental Data Science Small Core ETF
Proportion0.71%
Zacks Small/Mid Cap ETF
Proportion0.65%
SPDR S&P 600 Small Cap Growth ETF
Proportion0.47%
Vanguard S&P Small-Cap 600 Growth Index Fund
Proportion0.47%
iShares S&P Small-Cap 600 Growth ETF
Proportion0.45%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
